Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients.

@article{Briguori2011NovelAF,
  title={Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients.},
  author={Carlo Briguori and Flavio Airoldi and Gabriella Visconti and Amelia Focaccio and Gianluca Caiazzo and Bruno Golia and Giuseppe G. L. Biondi-Zoccai and Bruno Ricciardelli and Gerolama Condorelli},
  journal={Circulation. Cardiovascular interventions},
  year={2011},
  volume={4 2},
  pages={121-9}
}
BACKGROUND To expand the paucity of data on the efficacy of various drug-eluting stents in diabetic patients. METHODS AND RESULTS Type 2 diabetic patients treated in our institution from October 2005 to January 2007 presenting with of de novo lesions in native coronary arteries were randomly assigned to sirolimus-eluting stents (Cypher group; n=76); paclitaxel-eluting stents (Taxus group; n=75); and everolimus-eluting stents (Endeavor group; n=75). Poor metabolic control (HbA1c >7% and low… CONTINUE READING